Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,003 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05988892 | A Study of Physical Activity in Cancer Survivors | completed | N/A | 100 | Mayo ClinicOTHER | 1 | Mar 23, 2026 | clinicaltrials |
| NCT07089758 | A Study for Cerebral Open Flow Microperfusion | not yet recruiting | N/A | 6 | Mayo ClinicOTHER | 1 | Mar 23, 2026 | clinicaltrials |
| NCT03276832 |
| completed |
| Early Phase 1 |
| 7 |
| Mayo ClinicOTHER |
| 1 |
| Mar 19, 2026 |
| clinicaltrials |
| NCT07477886 | Ambient Sensing Room to Detect Early Signs of Adverse Events in Hospitalized Patients With Cancer | recruiting | — | 134 | Mayo ClinicOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT04007744 | Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors | active not recruiting | Phase 1 | 36 | Mayo ClinicOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT01721343 | Collaborative Targeted Case Management in Improving Functional Status in Patients With Stage III-IV Cancer | completed | N/A | 516 | Mayo ClinicOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT03155854 | The Effects of Prophylactic Limited Palmar Fasciectomy on Surgical Outcomes and Scarring | recruiting | N/A | 50 | Mayo ClinicOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT05112614 | Role of Gut Microbiome in Cancer Therapy | recruiting | — | 3,000 | Mayo ClinicOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT05294367 | Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma | recruiting | Early Phase 1 | 60 | Mayo ClinicOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT06109857 | Bladder Bank (a Prospective Banking Study) | recruiting | — | 1,500 | Mayo ClinicOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT06474091 | Liquid Biopsy MonitORing Of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO) | enrolling by invitation | — | 100 | Mayo ClinicOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT06483048 | MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer | recruiting | Phase 1 | 12 | Mayo ClinicOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT05033288 | Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone | recruiting | — | 72 | Mayo ClinicOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT06349642 | Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform(ELEPHAS-04) | recruiting | — | 324 | Mayo ClinicOTHER | 1 | Mar 12, 2026 | clinicaltrials |
| NCT00587314 | The Effect of Ablation Therapy on Barrett's Esophagus(ablation IN BE) | enrolling by invitation | — | 600 | Mayo ClinicOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT06036875 | CARE: Cancer Risk Perception and Women of Color | completed | — | 324 | Mayo ClinicOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT06151223 | A Prospective Registry for Patients at High-Risk for Pancreatic Cancer | recruiting | — | 5,000 | Mayo ClinicOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT00830557 | Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders | recruiting | — | 20,000 | Mayo ClinicOTHER | 1 | Mar 9, 2026 | clinicaltrials |
| NCT07456878 | Use of [18F] Fluoroethyl-L-tyrosine PET/MRI for Identifying Small Functional Pituitary Adenomas | recruiting | Phase 1 | 5 | Mayo ClinicOTHER | 1 | Mar 9, 2026 | clinicaltrials |
| NCT00835133 | Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and Melanoma | active not recruiting | — | 1,122 | Mayo ClinicOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT04144023 | A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ | recruiting | Phase 1 | 43 | Mayo ClinicOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT04474834 | Genetic Risk Estimations for Influencing Decision Making in Women at High Risk of Breast Cancer, GENRE 2 Study(GENRE2) | active not recruiting | — | 737 | Mayo ClinicOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT06525740 | Methadone Versus Intrathecal Hydromorphone for Postoperative Pain Relief in Gynecologic Cancer Undergoing Surgery | recruiting | Phase 4 | 140 | Mayo ClinicOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT04703244 | Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer | recruiting | — | 999 | Mayo ClinicOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT07243067 | Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer | not yet recruiting | — | 300 | Mayo ClinicOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT03159676 | Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer | completed | — | 150 | Mayo ClinicOTHER | 1 | Feb 25, 2026 | clinicaltrials |
| NCT04764942 | Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With Relapsed Refractory Multiple Myeloma, The SCOPE Trial | active not recruiting | Phase 1 / Phase 2 | 39 | Mayo ClinicOTHER | 1 | Feb 25, 2026 | clinicaltrials |
| NCT04897009 | Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Operable Breast Cancer(ENHANCE) | active not recruiting | — | 38 | Mayo ClinicOTHER | 1 | Feb 25, 2026 | clinicaltrials |
| NCT06217874 | Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer | recruiting | — | 2,000 | Mayo ClinicOTHER | 1 | Feb 25, 2026 | clinicaltrials |
| NCT03428581 | Preventing Lymphedema in Axillary Lymph Node Dissection | terminated | N/A | 264 | Mayo ClinicOTHER | 1 | Feb 24, 2026 | clinicaltrials |
| NCT06409000 | Evaluation of 3D Surface Scanning for Virtual-CT Based Radiation Therapy Treatment Planning | completed | — | 26 | Mayo ClinicOTHER | 1 | Feb 24, 2026 | clinicaltrials |
| NCT06918132 | Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer(N-PLANC) | recruiting | Phase 2 | 60 | Mayo ClinicOTHER | 1 | Feb 24, 2026 | clinicaltrials |
| NCT02958462 | Pre-myeloid Cancer and Bone Marrow Failure Clinic Study | recruiting | N/A | 2,000 | Mayo ClinicOTHER | 1 | Feb 23, 2026 | clinicaltrials |
| NCT06037863 | Evaluation of the Impact of Empty Versus Full Bladder in Patients With Prostate Cancer, RELIEF Trial | active not recruiting | N/A | 168 | Mayo ClinicOTHER | 1 | Feb 23, 2026 | clinicaltrials |
| NCT05703399 | Long Term Followup of Patients Enrolled in MC1137, BEAUTY Study | active not recruiting | — | 140 | Mayo ClinicOTHER | 1 | Feb 19, 2026 | clinicaltrials |
| NCT03445585 | Biobank for Cholestatic Liver Diseases. | recruiting | — | 9,150 | Mayo ClinicOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT04753996 | Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients | recruiting | — | 300 | Mayo ClinicOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT05297396 | Slow Opioid Tapering Pilot Study of Patients Using Chronic Opioid Therapy | completed | N/A | 18 | Mayo ClinicOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07407959 | Screening and Staging of Benign vs Malignant Pelvic Abnormalities | recruiting | — | 60 | Mayo ClinicOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07071051 | Exploring the Effect of Calaspargase Pegol on the Coagulation System in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients: Pilot Study | recruiting | — | 15 | Mayo ClinicOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT05677919 | Pirtobrutinib and Venetoclax With MRD Detection for Previously Untreated Chronic Lymphocytic Leukemia | active not recruiting | Phase 2 | 72 | Mayo ClinicOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT06764095 | Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial | recruiting | Phase 4 | 75 | Mayo ClinicOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT07104812 | Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS) | recruiting | Phase 2 | 15 | Mayo ClinicOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT01932697 | Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer | completed | Phase 2 | 81 | Mayo ClinicOTHER | 1 | Feb 10, 2026 | clinicaltrials |
| NCT05443971 | Durvalumab and Grid Therapy for Non-small Cell Lung Cancer in Progression During or After Treatment With PACIFIC Regimen | terminated | Phase 1 | 4 | Mayo ClinicOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT06600659 | A Study to Determine Number of Patients Who Develop High Ammonia Levels After Receiving Recombinant Erwinia Asparaginase | recruiting | — | 10 | Mayo ClinicOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT06117930 | Study of Human Brain-Gut Axis and Gut Microbiome in Patients With Brain Lesions - Repository for Neuroscience Research | recruiting | — | 100 | Mayo ClinicOTHER | 1 | Feb 5, 2026 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials